Amalgamated Bank Prothena Corp Public LTD CO Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Amalgamated Bank holds 1,440 shares of PRTA stock, worth $21,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,440
Previous 1,440 -0.0%
Holding current value
$21,916
Previous $30,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$24.75 - $40.66 $114,097 - $187,442
-4,610 Reduced 76.2%
1,440 $36,000
Q4 2023

Feb 06, 2024
SELL
$32.31 - $52.32 $8,949 - $14,492
-277 Reduced 4.38%
6,050 $220,000
Q3 2023

Nov 08, 2023
BUY
$47.3 - $70.6 $6,527 - $9,742
138 Added 2.23%
6,327 $305,000
Q2 2023

Aug 11, 2023
BUY
$48.26 - $78.59 $37,401 - $60,907
775 Added 14.31%
6,189 $422,000
Q1 2023

May 02, 2023
SELL
$46.97 - $58.27 $33,442 - $41,488
-712 Reduced 11.62%
5,414 $262,000
Q4 2022

Feb 10, 2023
BUY
$52.05 - $65.0 $21,132 - $26,390
406 Added 7.1%
6,126 $369,000
Q3 2022

Nov 09, 2022
BUY
$25.16 - $60.63 $2,239 - $5,396
89 Added 1.58%
5,720 $347,000
Q2 2022

Aug 15, 2022
BUY
$22.73 - $39.98 $2,045 - $3,598
90 Added 1.62%
5,631 $153,000
Q1 2022

Jun 30, 2022
SELL
$30.27 - $49.22 $11,199 - $18,211
-370 Reduced 6.26%
5,541 $203,000
Q4 2021

Feb 15, 2022
BUY
$42.11 - $73.26 $3,200 - $5,567
76 Added 1.3%
5,911 $292,000
Q3 2021

Oct 29, 2021
SELL
$48.2 - $78.89 $10,845 - $17,750
-225 Reduced 3.71%
5,835 $416,000
Q2 2021

Aug 16, 2021
BUY
$21.63 - $57.65 $131,077 - $349,359
6,060 New
6,060 $312,000
Q4 2017

Feb 13, 2018
SELL
$35.44 - $63.76 $172,663 - $310,638
-4,872 Closed
0 $0
Q3 2017

Nov 09, 2017
BUY
$53.83 - $67.75 $262,259 - $330,078
4,872
4,872 $316,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email